Home Cart Sign in  
Chemical Structure| 15442-64-5 Chemical Structure| 15442-64-5

Structure of Zinc Protoporphyrin
CAS No.: 15442-64-5

Chemical Structure| 15442-64-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Zinc Protoporphyrin is a competitive inhibitor of heme oxygenase-1 (HO-1) with anti-cancer activity, applied in cancer research and treatment.

Synonyms: Zn(II)-protoporphyrin IX; ZnPP; PROTOPORPHYRIN IX CONTAINING ZN

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Zinc Protoporphyrin

CAS No. :15442-64-5
Formula : C34H32N4O4Zn
M.W : 626.05
SMILES Code : CC1=C2C=C3C(C)=C(CCC([O-])=O)C(C=C(N4)C(CCC([O-])=O)=C(C)C4=CC5=NC(C(C)=C5C=C)=CC(N2)=C1C=C)=N3.[Zn+2]
Synonyms :
Zn(II)-protoporphyrin IX; ZnPP; PROTOPORPHYRIN IX CONTAINING ZN
MDL No. :MFCD00011612

Safety of Zinc Protoporphyrin

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
AG 1522 cells 5 µM 2 hours Znpp, a specific competitive inhibitor of HO-1, efficiently inhibited RAR, leading to an increase in MN yield from 34.8±2.2 to 58.9±3.6 per 1000 BN cells. Redox Biol. 2016 Aug;8:333-40
HCT-15 cells 10 µM 24 hours To detect the effect of ZnPP on HIF-1α and HO-1 expression. Results showed that ZnPP significantly reduced the expression levels of HIF-1α and HO-1. J Biomed Sci. 2016 Jan 28;23:18
HCT-15 cells 10 µM 24 hours To evaluate the inhibitory effect of ZnPP on HCT-15 cell proliferation. Results showed that 10 μM ZnPP significantly inhibited HCT-15 cell proliferation, reducing cell numbers by approximately 75%. J Biomed Sci. 2016 Jan 28;23:18
RAW 264.7 macrophages 5 µM 48 hours To investigate the effect of zinc protoporphyrin on cigarette smoke extract-induced ferroptosis in macrophages. Results showed that zinc protoporphyrin effectively prevented ferroptosis in M2 macrophages. MedComm (2020). 2024 Apr 12;5(4):e531
RAW 264.7 macrophages 5 µM 48 hours To investigate the effect of zinc protoporphyrin on cigarette smoke extract-induced ferroptosis in macrophages. Results showed that zinc protoporphyrin effectively prevented ferroptosis in M2 macrophages. Front Immunol. 2023 May 5;14:1162087
HepG2 cells 5 µM 6 and 12 hours ZnPP inhibits HepG2 cell proliferation and cyclin D1 expression J Biol Chem. 2009 Dec 25;284(52):36302-36311
SKOV3 cells 20 µM 9 hours To evaluate the cytotoxicity and cellular uptake of PEG-ZnPP. Results showed that PEG-ZnPP at 20 μM had no significant toxicity to SKOV3 cells and reached optimal uptake at 9 hours. Pharmaceutics. 2023 Sep 4;15(9):2275

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
BALB/c mice Gestational malaria model Subcutaneous injection 10 mg/kg/day Daily on gestational days 5, 6, and 7 HO-1 inhibition improved adverse pregnancy outcomes in malaria during early gestation, reducing parasitemia levels, iron deposition, and lipid peroxidation. Front Immunol. 2022 May 10;13:879158
Nude mice HCT-15 xenograft model Tail vein injection 100 μg Injected on days 11, 13, and 16 To evaluate the effect of ZnPP on tumor growth and angiogenesis. Results showed that ZnPP significantly reduced tumor nodule size, decreased the expression of angiogenesis marker αvβ3 integrin, and inhibited tumor growth. J Biomed Sci. 2016 Jan 28;23:18
Mice Ugt1 knockout mice (CN-I model) Subcutaneous injection 1-100 μmol/kg/day Once daily for 12 days To evaluate the therapeutic effect of zinc protoporphyrin on neonatal hyperbilirubinemia in Ugt1 knockout mice. Results showed that high-dose zinc protoporphyrin (100 μmol/kg/day) significantly reduced serum bilirubin levels and prevented neonatal lethality due to bilirubin neurotoxicity. Hepatol Commun. 2017 Oct;1(8):792-802
C57BL/6J mice B16-F10 melanoma model Intraperitoneal injection 20 mg/kg Once daily for 5 consecutive days ZnPP significantly inhibited the growth of B16-F10 melanoma, but the effect was largely abolished in Ido1?/? mice Mol Cancer Ther. 2010 Jun;9(6):1864-71
C57BL/6NCrl mice Cigarette smoke-induced COPD mouse model Intraperitoneal injection 25 mg/kg Once a week for 4 months To evaluate the effect of zinc protoporphyrin on the COPD mouse model. Results showed that zinc protoporphyrin significantly alleviated ferroptosis in alveolar macrophages and improved lung function and inflammatory responses. MedComm (2020). 2024 Apr 12;5(4):e531
C57BL/6NCrl mice Cigarette smoke-induced COPD mouse model Intraperitoneal injection 25 mg/kg Once a week for 4 months To evaluate the effect of zinc protoporphyrin on the COPD mouse model. Results showed that zinc protoporphyrin significantly alleviated ferroptosis in alveolar macrophages and improved lung function and inflammatory responses. Front Immunol. 2023 May 5;14:1162087
BALB/c female mice BCL1 tumor model Intraperitoneal injection 40 or 80 μM/kg Not specified ZnPP significantly inhibits BCL1 tumor growth and cyclin D1 expression J Biol Chem. 2009 Dec 25;284(52):36302-36311
Mice Isoproterenol-induced cardiotoxicity model Intraperitoneal injection 5 mg/kg Once daily for 3 weeks Inhibition of HO-1 activity, alleviating isoproterenol-induced cardiac necrosis, pathological remodeling, and heart failure Free Radic Biol Med. 2023 Oct;207:227-238
Female athymic nude mice Liver cancer xenograft model Intraperitoneal injection 5 mg/kg Once weekly for 6 weeks ZnPP IX (5 mg/kg) significantly enhanced the anticancer effects of CDDP (5 mg/kg), resulting in a significant reduction of tumor growth compared to tumors treated with CDDP alone. World J Gastroenterol. 2014 Jul 14;20(26):8572-82
BALB/c nude mice Ovarian cancer xenograft model Tail vein injection 9 μmol/kg Single injection, lasting 15 days To evaluate the antitumor effects of PEG-ZnPP-SDT in vivo. Results showed that the tumor suppression effect in the US + PEG-ZnPP group was significantly better than that in the US + PpIX and US + ZnPP groups. Pharmaceutics. 2023 Sep 4;15(9):2275

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.60mL

0.32mL

0.16mL

7.99mL

1.60mL

0.80mL

15.97mL

3.19mL

1.60mL

References

 

Historical Records

Categories